OTCPK:HDVY

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Health Discovery's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: HDVY's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-10.8%

HDVY

-4.9%

US Healthcare

-2.4%

US Market


1 Year Return

-70.0%

HDVY

17.9%

US Healthcare

12.0%

US Market

Return vs Industry: HDVY underperformed the US Healthcare industry which returned 17.9% over the past year.

Return vs Market: HDVY underperformed the US Market which returned 12% over the past year.


Shareholder returns

HDVYIndustryMarket
7 Day-10.8%-4.9%-2.4%
30 Day-29.8%-6.1%-6.5%
90 Day120.0%-0.8%8.4%
1 Year-70.0%-70.0%19.5%17.9%14.5%12.0%
3 Year725.0%725.0%20.8%15.5%34.8%25.8%
5 Year37.5%37.5%46.3%35.9%82.1%61.6%

Price Volatility Vs. Market

How volatile is Health Discovery's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Health Discovery undervalued compared to its fair value and its price relative to the market?

16.43x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate HDVY's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate HDVY's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: HDVY is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: HDVY is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HDVY's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: HDVY is overvalued based on its PB Ratio (16.4x) compared to the US Healthcare industry average (2.7x).


Next Steps

Future Growth

How is Health Discovery forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health Discovery has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Health Discovery performed over the past 5 years?

27.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HDVY is currently unprofitable.

Growing Profit Margin: HDVY is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: HDVY is unprofitable, but has reduced losses over the past 5 years at a rate of 27.5% per year.

Accelerating Growth: Unable to compare HDVY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HDVY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: HDVY has a negative Return on Equity (-47.84%), as it is currently unprofitable.


Next Steps

Financial Health

How is Health Discovery's financial position?


Financial Position Analysis

Short Term Liabilities: HDVY's short term assets ($1.7M) exceed its short term liabilities ($648.0K).

Long Term Liabilities: HDVY has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: HDVY's debt to equity ratio (20.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if HDVY's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HDVY has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: HDVY has sufficient cash runway for 1.2 years if free cash flow continues to grow at historical rates of 38.6% each year.


Next Steps

Dividend

What is Health Discovery current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HDVY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HDVY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HDVY's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HDVY's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HDVY's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.6yrs

Average board tenure


CEO

George McGovern (73 yo)

3.58yrs

Tenure

US$154,410

Compensation

Mr. George H. McGovern, III, has been the Chairman and Chief Executive Officer of Health Discovery Corporation since February 24, 2017. Mr. McGovern is a Co-Founder, Chairman and Chief Executive Officer at ...


CEO Compensation Analysis

Compensation vs Market: George's total compensation ($USD154.41K) is below average for companies of similar size in the US market ($USD606.53K).

Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
George McGovern
Chairman & CEO3.58yrsUS$154.41k20.07%
$ 2.7m
Marty Delmonte
President3.58yrsUS$125.00k1.36%
$ 181.5k
James Murphy
Independent Director3.42yrsUS$147.14k0.99%
$ 132.0k
Bernhard Schölkopf
Member of the Scientific Advisory Board16.83yrsno datano data
Kary Mullis
Member of the Scientific Advisory Boardno datano datano data
Ramananda Madyastha
Member of Scientific Advisory Boardno dataUS$120.00kno data
Vladimir Vapnik
Member of the Scientific Advisory Board16.17yrsno datano data
Thomas Stamey
Member of Scientific Advisory Board16.17yrsno datano data
Edward Morrison
Independent Director3.42yrsUS$147.14k2.6%
$ 346.5k
Colleen Hutchinson
Director2.33yrsUS$147.14k0.99%
$ 132.0k
William Fromholzer
Independent Director2.33yrsUS$147.14k0.99%
$ 132.0k

3.6yrs

Average Tenure

64yo

Average Age

Experienced Board: HDVY's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.8%.


Top Shareholders

Company Information

Health Discovery Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Health Discovery Corporation
  • Ticker: HDVY
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$13.333m
  • Shares outstanding: 404.04m
  • Website: https://www.healthdiscoverycorp.com

Number of Employees


Location

  • Health Discovery Corporation
  • 2002 Summit Boulevard, NE
  • Suite 300
  • Atlanta
  • Georgia
  • 30319
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HDVYOTCPK (Pink Sheets LLC)YesCommon StockUSUSDNov 2001

Biography

Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United St ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/26 06:32
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.